State of Wisconsin Investment Board
AMRX icon

State of Wisconsin Investment Board’s Amneal Pharmaceuticals AMRX Stock Holding History

State of Wisconsin Investment Board’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.67M Sell
133,968
-34,522
-20% -$464K ﹤0.01% 1473
2025
Q4 		$2.12M Buy
168,490
+68,374
+68% +$782K ﹤0.01% 1385
2025
Q3 		$1M Buy
100,116
+23,067
+30% +$207K ﹤0.01% 1618
2025
Q2 		$623K Sell
77,049
-57,346
-43% -$432K ﹤0.01% 1764
2025
Q1 		$1.13M Buy
134,395
+1,536
+1% +$12.8K ﹤0.01% 1450
2024
Q4 		$1.05M Sell
132,859
-315
-0.2% -$2.64K ﹤0.01% 1507
2024
Q3 		$1.11M Sell
133,174
-20,400
-13% -$160K ﹤0.01% 1532
2024
Q2 		$975K Sell
153,574
-47,294
-24% -$300K ﹤0.01% 1561
2024
Q1 		$1.22M Buy
200,868
+85,633
+74% +$483K ﹤0.01% 1377
2023
Q4 		$699K Buy
115,235
+92,535
+408% +$412K ﹤0.01% 1520
2023
Q3 		$95.8K Buy
+22,700
New +$84.7K ﹤0.01% 2370
2023
Q2 		– Sell
-12,462
Closed -$17.3K – 2349
2023
Q1 		$17.3K Sell
12,462
-80,236
-87% -$160K ﹤0.01% 2497
2022
Q4 		$184K Sell
92,698
-5,664
-6% -$12.7K ﹤0.01% 2263
2022
Q3 		$199K Sell
98,362
-5,454
-5% -$15.3K ﹤0.01% 2408
2022
Q2 		$330K Sell
103,816
-35,284
-25% -$128K ﹤0.01% 2279
2022
Q1 		$580K Hold
139,100
– – ﹤0.01% 1757
2021
Q4 		$666K Hold
139,100
– – ﹤0.01% 1585
2021
Q3 		$743K Hold
139,100
– – ﹤0.01% 1550
2021
Q2 		$712K Hold
139,100
– – ﹤0.01% 1574
2021
Q1 		$936K Sell
139,100
-72,000
-34% -$399K ﹤0.01% 1382
2020
Q4 		$965K Sell
211,100
-55,500
-21% -$246K ﹤0.01% 1340
2020
Q3 		$1.03M Buy
266,600
+64,900
+32% +$278K ﹤0.01% 1283
2020
Q2 		$960K Buy
201,700
+19,200
+11% +$79.1K ﹤0.01% 1247
2020
Q1 		$635K Buy
182,500
+42,000
+30% +$178K ﹤0.01% 1284
2019
Q4 		$677K Hold
140,500
– – ﹤0.01% 1347
2019
Q3 		$407K Buy
140,500
+14,500
+12% +$50.6K ﹤0.01% 1388
2019
Q2 		$903K Sell
126,000
-109,700
-47% -$1.12M ﹤0.01% 1169
2019
Q1 		$3.34M Buy
235,700
+26,400
+13% +$349K 0.01% 901
2018
Q4 		$2.83M Buy
209,300
+500
+0.2% +$9.01K 0.01% 903
2018
Q3 		$4.63M Buy
208,800
+120,300
+136% +$2.53M 0.01% 895
2018
Q2 		$1.45M Buy
+88,500
New +$1.55M ﹤0.01% 1060

Other funds holding AMRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State of Wisconsin Investment Board's AMRX Position: Q1 2026 in Review

State of Wisconsin Investment Board reduced its Amneal Pharmaceuticals (AMRX) stake by 20% in Q1 2026, selling an estimated $464K and leaving 133,968 shares worth $1.67M. The position accounts for ﹤0.01% of the portfolio, ranked #1473.

State of Wisconsin Investment Board first reported a position in AMRX in Q2 2018 and has held it in 31 quarters since. The position peaked at $4.63M in Q3 2018. 316 funds tracked by Wall St. Rank hold AMRX as of Q1 2026.

  • State of Wisconsin Investment Board held 133,968 shares of Amneal Pharmaceuticals worth $1.67M as of Q1 2026.
  • State of Wisconsin Investment Board sold 34,522 Amneal Pharmaceuticals shares in Q1 2026, an estimated $464K.
  • Amneal Pharmaceuticals made up ﹤0.01% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #1473 holding.
  • State of Wisconsin Investment Board first reported a position in Amneal Pharmaceuticals in Q2 2018 and has held it in 31 quarters since.
  • State of Wisconsin Investment Board's Amneal Pharmaceuticals position peaked at $4.63M in Q3 2018.
  • 316 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q1 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.